4

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: May 16, 2017
Period of Report: May 16, 2017
Accession Number: 0001144204-17-027803

View Document ↗ View on SEC.gov ↗